Clinical Trial

Microglial Activation in Inflammatory Bowel Disease

Study Description

Microglial Activation in Inflammatory Bowel Disease

The purpose of this study is to monitor microglial activation in participants with inflammatory bowel disease (IBD) and investigate the relationship that exists between these patients and their risk of acquiring major depressive episodes (MDE). Patients with both IBD and MDE will be subsequently approached to participate in the study.

Location

Locations Selected Location

Methods

No pharmaceutical medication involved No pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Radiation - [18F]FEPPA

up to 3 PET Scans ([18F]FEPPA PET scans done 3 to 6 months apart, and one [11C]SL2511.88 PET scan) and 1 MRI

Additional Information

Official Study Title

Naturalistic Monitoring of Microglial Activation in Inflammatory Bowel Disease

Clinical Trial ID

NCT03487926

ParticipAid ID

rb2jAb